First Wave BioPharma, Inc. (FWBI) financial statements (2022 and earlier)

Company profile

Business Address 777 YAMATO ROAD
BOCA RATON, FL 33431
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,2496,0621761,1145731,774
Cash and cash equivalents8,2496,0621761,1145731,774
Receivables 5512,6373,1731,104961
Prepaid expense1,1761,256595513275229
Total current assets:9,4257,8703,4084,8001,9532,964
Noncurrent Assets
Operating lease, right-of-use asset 7482
Property, plant and equipment731877129134152
Intangible assets, net (including goodwill) 4,9345,2941,9252,0161,768
Goodwill 2,0541,8871,9252,0161,768
Intangible assets, net (excluding goodwill) 2,8803,407   
Other noncurrent assets2,292     
Other undisclosed noncurrent assets 28416161,3771,871
Total noncurrent assets:2,3655,0545,4952,6693,5273,790
TOTAL ASSETS:11,79012,9248,9037,4695,4806,754
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,1011,6861,7552,0701,1871,471
Accounts payable2,6821,6861,7552,0701,1871,471
Accrued liabilities4191277128526274
Employee-related liabilities   253220325
Interest and dividends payable  113 77
Other undisclosed accounts payable and accrued liabilities (127)(184)(538)(489)(406)
Debt6415521,521255417155
Due to related parties  533670868707
Other liabilities8,09357476   
Other undisclosed current liabilities46513,250  77
Total current liabilities:12,30015,5454,2862,9962,4792,341
Noncurrent Liabilities
Liabilities, other than long-term debt7,31119    
Other liabilities7,31119    
Other undisclosed noncurrent liabilities    1,3401,200
Total noncurrent liabilities:7,31119  1,3401,200
Total liabilities:19,61215,5654,2862,9963,8193,541
Stockholders' equity
Stockholders' equity attributable to parent(7,822)(2,641)4,6174,4741,6613,213
Common stock133211
Additional paid in capital147,30593,83568,57653,13937,67027,561
Accumulated other comprehensive loss(1,224)(1,113)(1,267)(1,150)(956)(1,462)
Accumulated deficit(153,904)(95,366)(62,695)(47,517)(33,983)(22,887)
Stockholders' equity note, subscriptions receivable    (1,071) 
Total stockholders' equity:(7,822)(2,641)4,6174,4741,6613,213
TOTAL LIABILITIES AND EQUITY:11,79012,9248,9037,4695,4806,754

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues
(Net Investment Income)
 0    
Gross profit: 0    
Operating expenses(59,057)(26,433)(14,744)(13,222)(10,081)(6,625)
Other operating expense, net
(Other Expenses)
  (434)   
Other undisclosed operating income (loss) (0) (210)(140)300
Operating loss:(59,057)(26,433)(15,178)(13,432)(10,221)(6,325)
Nonoperating income519     
Interest and debt expense(11)(610)(434)(102)(875)(5,937)
Loss from continuing operations before equity method investments, income taxes:(58,549)(27,043)(15,612)(13,534)(11,096)(12,263)
Other undisclosed loss from continuing operations before income taxes (5,629)   (2,329)
Net loss:(58,549)(32,671)(15,612)(13,534)(11,096)(14,592)
Other undisclosed net income attributable to parent11 434   
Net loss attributable to parent:(58,538)(32,671)(15,178)(13,534)(11,096)(14,592)
Preferred stock dividends and other adjustments(465)906    
Other undisclosed net loss available to common stockholders, basic(25,515)(9,967)    
Net loss available to common stockholders, diluted:(84,519)(41,732)(15,178)(13,534)(11,096)(14,592)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(58,549)(32,671)(15,612)(13,534)(11,096)(14,592)
Comprehensive loss:(58,549)(32,671)(15,612)(13,534)(11,096)(14,592)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(100)(154)317(194)506(116)
Comprehensive loss, net of tax, attributable to parent:(58,649)(32,825)(15,294)(13,728)(10,590)(14,707)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: